Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Current Opinion in Oncology|January 11, 2022
Recent advances in radiosensitivity determinants in melanomaMohammad Krayem, Ghanem E Ghanem, Dirk Van Gestel
International Journal of Molecular Sciences|December 21, 2017
Galectins and Carcinogenesis: Their Role in Head and Neck Carcinomas and Thyroid CarcinomasNadège Kindt, Fabrice Journe, Ghanem E Ghanem, et al.
Pharmacological Research|September 12, 2022
Bufalin for an innovative therapeutic approach against cancerLaura Soumoy, Ghanem E Ghanem, Sven Saussez, et al.
Molecular Imaging|May 9, 2013
Electron paramagnetic resonance spectrometry and imaging in melanomas: comparison between pigmented and nonpigmented human malignant melanomasQuentin Godechal, Ghanem E Ghanem, Martin G Cook, et al.
Biomedicines|July 27, 2022
Cytokine Landscape in Central Nervous System MetastasesJulie Marin, Fabrice Journe, Ghanem E Ghanem, et al.
Nuclear Medicine and Biology|April 11, 2021
Investigating intrinsic radiosensitivity biomarkers to peptide receptor radionuclide therapy with [<sup>177</sup>Lu]Lu-DOTATATE in a panel of cancer cell linesWendy Delbart, Ghanem E Ghanem, Ioannis Karfis, et al.
Cancers|April 30, 2021
RTK Inhibitors in Melanoma: From Bench to BedsideMalak Sabbah, Ahmad Najem, Mohammad Krayem, et al.
Cells|April 12, 2022
Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of MelanomaAhmad Najem, Laura Soumoy, Malak Sabbah, et al.
Oncotarget|August 31, 2018
Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanomaMohammad Krayem, Ahmad Najem, Fabrice Journe, et al.
Talanta|December 17, 2008
Improving the spectrophotometric determination of the alkylating activity of anticancer agents: a new insight into the mechanism of the NBP methodKaren M E Dierickx, Fabrice Journé, Pascal Gerbaux, et al.
Pageof 4